Foreword by the UEMS: Vassilios Papalois: President -- Foreword by C Markopoulos, President of Division of Breast Surgery -- Foreword by ESSO: Tibor Kovacs, President -- Foreword by EUSOMA: Isobel Rubio, President -- Section 1. LW and CM to lead -- Anatomy and physiology of the breast and axilla. -- Epidemiology of breast cancer and risk factors -- The genetic basis of breast cancer, risk assessment and management -- Breast screening in normal and high risk populations -- Breast pathology (including multifocal, multicentric, biological subtypes, gene arrays, margins) -- Breast imaging -- Diagnosis and staging of breast cancer -- DCIS -- Section 2. Surgery to the breast and axilla. IR and LW to lead -- Mastectomy (including SSM, NSM) -- Breast conservation -- Axillary surgery and management, including SLNB, ANC, tSLNB, axillary RT, Z11, adverse effects such as lymphoedema. -- Surgery for stage 3, stage 4 and locally recurrent disease (including surgical principles after NACT) -- Section 3. Oncoplastic and reconstructive surgery. LW and TK -- Therapeutic mammoplasty: oncology, techniques, outcomes. -- Breast reconstruction (immediate and delayed, immediate delayed, techniques, oncology, RT impacts, implants, flaps etc) -- Lipomodelling -- Breast implants (to include types, practical aspects of use, adverse events including BIALCL, leakage, capsule formation etc -- Section 4. Adjuvant and neoadjuvant therapies. LW and CM -- Endocrine therapy -- Chemotherapy -- Biological therapy -- Bisphosphonates -- Radiotherapy (IMRT, CT, Protons, IORT, brachytherapy) -- Section 5. Management of metastatic breast cancer, LW and CM -- Systemic therapy -- Surgery for metastatic disease (oligometastatic, primary cancer, bone metastases) -- Radiotherapy for metastatic disease: bone, soft tissue, brain (SABR, gamma knife) -- Section 6. Breast cancer in special groups, LW and CM -- Elderly -- Young patients, including fertility preservation, BRCA carriers -- Pregnancy -- Male BC -- Occult primary -- Section 7. The academic viva. CM -- Statistics for clinical trials -- How to critique a paper -- Key trials.